BlackRock Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $88K | Sell |
18,942
-738
| -4% | -$3.43K | ﹤0.01% | 3010 |
|
2016
Q3 | $152K | Buy |
19,680
+1,549
| +9% | +$12K | ﹤0.01% | 2764 |
|
2016
Q2 | $110K | Buy |
18,131
+2,296
| +14% | +$13.9K | ﹤0.01% | 2872 |
|
2016
Q1 | $135K | Sell |
15,835
-422
| -3% | -$3.6K | ﹤0.01% | 2719 |
|
2015
Q4 | $194K | Sell |
16,257
-7,116
| -30% | -$84.9K | ﹤0.01% | 2551 |
|
2015
Q3 | $236K | Buy |
23,373
+328
| +1% | +$3.31K | ﹤0.01% | 2591 |
|
2015
Q2 | $382K | Buy |
23,045
+5,202
| +29% | +$86.2K | ﹤0.01% | 2339 |
|
2015
Q1 | $276K | Buy |
17,843
+3,191
| +22% | +$49.4K | ﹤0.01% | 2461 |
|
2014
Q4 | $232K | Buy |
14,652
+1,141
| +8% | +$18.1K | ﹤0.01% | 2509 |
|
2014
Q3 | $144K | Buy |
13,511
+3,660
| +37% | +$39K | ﹤0.01% | 2769 |
|
2014
Q2 | $93K | Buy |
9,851
+227
| +2% | +$2.14K | ﹤0.01% | 3052 |
|
2014
Q1 | $66K | Buy |
9,624
+2,114
| +28% | +$14.5K | ﹤0.01% | 3160 |
|
2013
Q4 | $29K | Buy |
7,510
+366
| +5% | +$1.41K | ﹤0.01% | 3306 |
|
2013
Q3 | $36K | Buy |
7,144
+1,457
| +26% | +$7.34K | ﹤0.01% | 3235 |
|
2013
Q2 | $36K | Buy |
+5,687
| New | +$36K | ﹤0.01% | 3209 |
|